Cargando…
Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
BACKGROUND: Chronic kidney Failure (CKD), particularly End-Stage Renal Disease (ESRD), may be serious ill-health related to a high death rate. Uremic syndrome leads to increased oxidative stress, inflammation, and dyslipidemia. Our study aimed at identifying the association of NOS3 (rs 2070744) and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523625/ https://www.ncbi.nlm.nih.gov/pubmed/34661767 http://dx.doi.org/10.1186/s43141-021-00260-w |
_version_ | 1784585334339665920 |
---|---|
author | Elsaid, Afaf Samir eid, Omnia Said, Samy B. Zahran, Rasha F. |
author_facet | Elsaid, Afaf Samir eid, Omnia Said, Samy B. Zahran, Rasha F. |
author_sort | Elsaid, Afaf |
collection | PubMed |
description | BACKGROUND: Chronic kidney Failure (CKD), particularly End-Stage Renal Disease (ESRD), may be serious ill-health related to a high death rate. Uremic syndrome leads to increased oxidative stress, inflammation, and dyslipidemia. Our study aimed at identifying the association of NOS3 (rs 2070744) and SOD2 Val16Ala (rs4880) gene polymorphisms within ESRD Egyptian patients. METHODS: This work was conducted on 100 ESRD and 16 CKD Egyptian patients who were compared to 100 healthy controls. DNA was genotyped for these variants using the (T-ARMS-PCR) technique. RESULTS: ESRD patients showed a significant association of the genotype of NOS3 gene polymorphism compared with healthy controls (P = 0.032). In the contrast, the present study revealed that no statistically significant differences were found among the CKD, ESRD, and control groups as regards the SOD2 genotypes (P = 0.064). CONCLUSIONS: Our findings indicated a significant association between NOS3 (rs 2070744) gene polymorphism and increased risk of ESRD and CKD among Egyptian patients. |
format | Online Article Text |
id | pubmed-8523625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85236252021-10-27 Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients Elsaid, Afaf Samir eid, Omnia Said, Samy B. Zahran, Rasha F. J Genet Eng Biotechnol Research BACKGROUND: Chronic kidney Failure (CKD), particularly End-Stage Renal Disease (ESRD), may be serious ill-health related to a high death rate. Uremic syndrome leads to increased oxidative stress, inflammation, and dyslipidemia. Our study aimed at identifying the association of NOS3 (rs 2070744) and SOD2 Val16Ala (rs4880) gene polymorphisms within ESRD Egyptian patients. METHODS: This work was conducted on 100 ESRD and 16 CKD Egyptian patients who were compared to 100 healthy controls. DNA was genotyped for these variants using the (T-ARMS-PCR) technique. RESULTS: ESRD patients showed a significant association of the genotype of NOS3 gene polymorphism compared with healthy controls (P = 0.032). In the contrast, the present study revealed that no statistically significant differences were found among the CKD, ESRD, and control groups as regards the SOD2 genotypes (P = 0.064). CONCLUSIONS: Our findings indicated a significant association between NOS3 (rs 2070744) gene polymorphism and increased risk of ESRD and CKD among Egyptian patients. Springer Berlin Heidelberg 2021-10-18 /pmc/articles/PMC8523625/ /pubmed/34661767 http://dx.doi.org/10.1186/s43141-021-00260-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Elsaid, Afaf Samir eid, Omnia Said, Samy B. Zahran, Rasha F. Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients |
title | Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients |
title_full | Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients |
title_fullStr | Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients |
title_full_unstemmed | Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients |
title_short | Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients |
title_sort | association of nos3 (rs 2070744) and sod2val16ala (rs4880) gene polymorphisms with increased risk of esrd among egyptian patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523625/ https://www.ncbi.nlm.nih.gov/pubmed/34661767 http://dx.doi.org/10.1186/s43141-021-00260-w |
work_keys_str_mv | AT elsaidafaf associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients AT samireidomnia associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients AT saidsamyb associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients AT zahranrashaf associationofnos3rs2070744andsod2val16alars4880genepolymorphismswithincreasedriskofesrdamongegyptianpatients |